Diabetes

A prospective cohort study found that women who replaced processed red meat with fatty fish, unprocessed red meat, or vegetables had reduced risks of hypertension and diabetes.

A population-based cohort study of Hispanic Americans found that people who walked more per day had a lower risk of being diagnosed with type 2 diabetes.

While cognitive behavioral therapy (CBT) is known to be effective for generalized depression and anxiety, it is only recently that research has begun exploring its specific use in diabetes, including looking at the effects on depression, anxiety, and glycemic control.

Amazon will shut down its telehealth venture Amazon Care by the end of 2022; youth type 2 diabetes (T2D) diagnoses rose by 77% in the first year of the COVID-19 pandemic; officials during Donald Trump’s presidency tried to push for the FDA reauthorization of a discredited COVID-19 treatment.

According to this systematic review, the best way to optimize diabetes management for patients with both diabetes and intellectual disabilities is supported self-management, which has numerous obstacles to full implementation.

The results suggest that dipeptidyl peptidase-4 (DDP-4) inhibitors, which are widely prescribed in Germany, are not a cost-effective option despite lower drug pricing compared with empagliflozin.

A cross-sectional association was found between plasma prostasin level and risk of diabetes and cancer mortality in patients with high blood glucose levels.

For vision-threatening diseases, such as diabetic macular edema (DME) understanding the economic value of treatments can help identify the direct and indirect benefits of different treatments, said Paul Hahn, MD, vitreoretinal surgeon at NJRetina.

This study presents an integrated, exploratory assessment of physical activity, patient activation, health-related quality of life, and clinical outcomes among older adults with type 2 diabetes (T2D) using survey, wellness, and claims data.

HR 5376, or the Inflation Reduction Act, is most significant piece of legislation affecting federal health policy since the passage of the Affordable Care Act in 2010; for Medicare beneficiaries, it caps insulin at $35 a month and includes other pricing reforms.

During the 2022 Congress of the American Society for Preventive Cardiology (ASPC), held in Louisville, Kentucky, Erin D. Michos, MD, MHS, of Johns Hopkins, and Pam R. Taub, MD, of UC San Diego Health, discussed how treatment of diabetes requires going beyond glucose-lowering therapies and including newer medications that offer cardiovascular benefits.

Following a time-restricted eating schedule, limited to a 10-hour window, provides beneficial metabolic effects and the potential for weight loss in patients with type 2 diabetes, according to a new study.

Researchers suggest that annual wellness visits for patients with diabetes lead to earlier diagnoses of complications, preventing amputations and serious consequences.

A recent review found that there were several modifiable and nonmodifiable factors that can affect the treatment adherence of patients with type 2 diabetes (T2D).

A recent study characterized the known association between corticosteroid exposure and type 2 diabetes (T2D), finding risk to be associated with treatment- and patient-related characteristics that can inform prescription of treatment with steroids.

Although prediabetes prevalence jumped 4.8 percentage points from 2010 to 2020, barriers to accessing diabetes prevention interventions persist, driven by cost, eligibility requirements, and data integration, leading to low participation rates.

President Joe Biden will sign an executive order to protect access to the abortion pill and emergency contraception; Governor Gavin Newsom announced California will make low-cost insulin; CMS proposed a rule that would bring major reforms to the accountable care organization program.

Christopher Thompson, MD, MSc, FASGE, FACG, AGAF, FJGES, director of endoscopy and codirector of the Center for Weight Management and Wellness at Brigham & Women’s Hospital, professor of medicine at Harvard Medical School, discusses a session on gastrointestinal (GI) invention at the recent conference, Digestive Disease Week, held May 21-24 in San Diego, California.

Christopher Thompson, MD, MSc, FASGE, FACG, AGAF, FJGES, director of endoscopy and codirector of the Center for Weight Management and Wellness at Brigham & Women’s Hospital, professor of medicine at Harvard Medical School, discusses duodenal jejunal bypass liner treatment and future innovations in gastroenterology.

Data from menstrual tracking apps may be used against people in certain states if Roe v Wade is overturned; 100 million Americans, including 41% of adults, have health care debt; Express Scripts reported results of its program to lower diabetes-related costs.

Researchers found significantly higher incidence rates of of type 2 diabetes (T2D) in children with nonalcoholic fatty liver disease compared with other groups.

About 3 times as many of the children and teenagers taking dulaglutide had a glycated hemoglobin level of less than 7.0% at 26 weeks compared with those on placebo.

Results of a cross-sectional study revealed wide disparities in emergency department (ED) use among patients with diabetes between 2008 and 2017.

Results of a randomized controlled trial found supplementation with vitamin D among those at risk for type 2 diabetes (T2D) did not prevent onset of the disease.

Findings of this study showed arterial stiffness is associated with a higher risk of diabetes onset compared with hypertension.